Acadia Pharmaceuticals ACAD Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Acadia Pharmaceuticals's financing cash flow?
- Acadia Pharmaceuticals (ACAD) reported financing cash flow of $4.23M in Q1 2026.
- How has Acadia Pharmaceuticals's financing cash flow changed year-over-year?
- Acadia Pharmaceuticals's financing cash flow increased by 130.2% year-over-year, from $1.84M to $4.23M.
- What is the long-term trend for Acadia Pharmaceuticals's financing cash flow?
- Over 4 years (2021 to 2025), Acadia Pharmaceuticals's financing cash flow has grown at a 28.7% compound annual growth rate (CAGR), from $18.16M to $49.88M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.